Not everyone can do this. Introducing RayOne with patented Lock & Roll TM technology for the smallest fully preloaded IOL incision

Similar documents
RayOne Hydrophobic IOL. New design. New standard MADE IN UK

Product Portfolio. Sulcoflex Pseudophakic Supplementary IOLs

Product Portfolio. Sulcoflex Pseudophakic Supplementary IOLs. Your skill. Our vision.

Sulcoflex. For when perfection is the only option! Pseudophakic Sulcus Fixated Secondary IOLs. Sulcoflex Aspheric. Sulcoflex Toric

Unique Aberration-Free IOL: A Vision that Patients

Long-term quality of vision is what every patient expects

ROTATIONAL STABILITY MAKES THE DIFFERENCE

PROGRESSIVE VISION WITHIN FULL ACCOMMODATIVE RANGE

day night convinced supreme contrast sensitivity THE IOL FOR DAY & NIGHT

IOL Types. Hazem Elbedewy. M.D., FRCS (Glasg.) Lecturer of Ophthalmology Tanta university

Glistening-Free Hydrophobic Acrylic IOL. Glistening-Free Hydrophobic Acrylic IOL

The design is distinctive. The outcomes are clear. Defocus tolerance 1 Glistening-free performance 1,2 Predictable outcomes 1

AT LISA tri 839MP and AT LISA tri toric 939MP from ZEISS The innovative trifocal IOL concept providing True Living Vision to more patients

NOW. Approved for NTIOL classification from CMS Available in Quar ter Diopter Powers. Accommodating. Aberration Free. Aspheric.

COMPARISON OF THE MEDICONTUR 860FAB

NEW. AT LISA tri 839MP and AT LISA tri toric 939MP from ZEISS The innovative trifocal IOL concept providing True Living Vision to more patients

SEE BEYOND WITH FULLRANGE OPTICS. Developed by Hanita Lenses

Clinical Evaluation 3-month Follow-up Report

I N M A D E F R A N C E. Hydrophobic monofocal NEW QUALITY SAFETY STABILITY TECHNICAL BROCHURE

Improving Lifestyle Vision. with Small Aperture Optics

HYDROPHILIC ACRYLIC ADVANCED POLYMER

CONTENTS. HYDROPHILIC IOLs. Bi-Flex PIL-MA hydrophilic preloaded P / PY 677PT / PTY 677PMY 677PMTY. Bi-Flex HL...

THE ASPHERIC PRELOADED INJECTION

Maximum Light Transmission. Pupil-independent Light Distribution. 3.75D Near Addition Improved Intermediate Vision

IOL Review and FLACS Update

Dr. Magda Rau Eye Clinic Cham, Germany

Maximising Treatment Outcomes with Premium IOL Technology. Saturday 13 September 2014 XXXII Congress of the ESCRS London, UK.

*Simulated vision. **Individual results may vary and are not guaranteed. Visual Performance When It s Needed Most

UIN: IOL Date of Prep: April Avansee Preload1P. Technical Slide Kit April 2017

Wide Diopter Range and Different Haptic Platforms

Advances in the design and

Quality of Vision With Multifocal Progressive Diffractive Lens: Two-Year Follow-up

THE XTRAFOCUS IS AN ELEGANT SOLUTION TO COMPLEX CASES.

NEW THE WORLD S FIRST AND ONLY SINUSOIDAL TRIFOCAL IOL

Causes of refractive error post premium IOL s 3/17/2015. Instruction course: Refining the Refractive Error After Premium IOL s.

Evolution of Diffractive Multifocal Intraocular Lenses

The complete choice in refractive lens solutions

FEA of Prosthetic Lens Insertion During Cataract Surgery

Sulcoflex Pseudophakic Supplementary IOLs

Preloaded. PreciSAL. EZ Toric

PreciSAL Preloaded Lens System

ASPIRA PUBLICATION LIST

Aberrations Before and After Implantation of an Aspheric IOL

EDoF IOL. ZEISS AT LARA 829MP Next generation Extended Depth of Focus Intraocular Lens. NEW EDoF IOL from ZEISS

Comparison of Anterior Capsule Stability Following Implantation of Three Single Piece Acrylic Intraocular Lenses with Different Haptic Design

Intraocular lens Difficulties

Treatment of Presbyopia during Crystalline Lens Surgery A Review

Clinical Evaluation 3-month Follow-up Report

Sutureless, Glueless, Scleral Fixation of Single-Piece and Toric Intraocular Lens: A Novel Technique

Retinal stray light originating from intraocular lenses and its effect on visual performance van der Mooren, Marie Huibert

Comparison of higher order aberrations with spherical and aspheric IOLs compared to normal phakic eyes

Crystalens AO: Accommodating, Aberration-Free, Aspheric Y. Ralph Chu, MD Chu Vision Institute Bloomington, MN

Multifocal Intraocular Lenses for the Treatment of Presbyopia: Benefits and Side-effects

Multifocal Progressive Diffractive Lens to Improve Light Distribuition and Avoid Light Loss: Two Years Clinical Results

7 DO IT. A SAFER WAY TO TRIFOCALITY * : ELEVATED PHASE SHIFT (EPS) ** 7 DIFFRACTIVE RINGS FOR OPTIMAL LIGHT DISTRIBUTION AND LESS DISTURBANCE

(12) United States Patent (10) Patent No.: US 7,156,854 B2

Comparative Study Between the High Order Aberrations Before and After Cataract Surgery Using Two Different Types of IOLS

IOL Predictions for the Coming Year

Advanced Technology IOLs

Financial disclosure. Alcon, Zeiss, J&J AMO, Physiol, Thea, Allergan, Santen, Dompe, Cutting Edge) Race for Progress!

HOYA aspherical IOL with ABC (Aspheric Balanced Curve) Design

Multifocal and Accommodative

New CONNECTING VISIONS

Raise your expectations. Deliver theirs.

Centre Hospitalier Universitaire et Psychiatrique de Mons-Borinage. B-Flex Multifocal. Dr Emmanuel Van Acker Belgium

Medicontur IOLs: Materials & Design Main Characteristics

The Blueprint for Improved Image Quality

Special Publication: Ophthalmochirurgie Supplement 2/2009 (Original printed issue available in the German language)

Amico Yasna Pars. What s Inside. Leader in Healthcare Specialty Markets. Ophthalmology Newsletter.

Visual Outcomes of Two Aspheric PCIOLs: Tecnis Z9000 versus Akreos AO

Accommodating IOL s History and Clinical Management

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Customized intraocular lenses

Easy to identify: The color-coded forceps and scissors make identification during September September September 2016

EDOF-IOLs: Are they all the same?

THE BEST OF BOTH WORLDS Dual-Scheimpflug and Placido Reaching a new level in refractive screening

Wavefront Aberrations in Eyes With Acrysof Monofocal Intraocular Lenses

Headline. IOLMaster. Subline. The gold standard in biometry

FOR PRECISE ASTIGMATISM CORRECTION.

Update on Aspheric IOL Technology

EXCHANGE. Financial Disclosure. Clinical pearls In advanced anterior segment surgery being able to do a IOL exchange is a must. Why Do an Exchange

The Aberration-Free IOL:

Evolution of the Cataract Patient

AHEAD Superior technology, thoughtfully designed with you in mind for an intelligent approach to cataract surgery.

Modified Peripheral Iris Fixation of a Foldable Intraocular Lens Following Phacoemulsification

Evaluation of the Impact of Intraocular Lens Tecnis Z9000 Misalignment on the Visual Quality Using the Optical Eye Modeling

In vitro comparative optical bench analysis of a spherical and aspheric optic design of the same IOL model

University of Groningen. Young eyes for elderly people van Gaalen, Kim

Patient information. Your options for cataract treatment Enjoy clear vision at all distances with multifocal IOLs

Roadmap to presbyopic success

12 10) Patent No.: US 8.663,235 B2. Tassignon (45) Date of Patent: Mar. 4, 2014 (54) BAG-IN-THE-LENS INTRAOCULAR LENS FOREIGN PATENT DOCUMENTS

Ophthalmic use of human amniotic membrane INTERNATIONAL. Principle features of the MICS-IOLs currently available

József Győry. Veszprem, Hungary

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/16

Optical Connection, Inc. and Ophthonix, Inc.

Clinical Update for Presbyopic Lens Options

OCULUS Pentacam AXL Always an Axial Length Ahead

Image quality in polypseudophakia for extremely short eyes

Refractive Power / Corneal Analyzer. OPD-Scan III

Choosing the Proper Power for the IOL. Brannon Aden, MD Miles H. Friedlander, MD, FACS

Transcription:

Not everyone can do this Introducing RayOne with patented Lock & Roll TM technology for the smallest fully preloaded IOL incision

RayOne fully preloaded IOL injection system, designed to deliver without compromise The need The solution Talking to surgeons indicates that they are looking for an injector that can deliver an IOL consistently, with expert control, through a micro incision with minimal wound stretch. The dilemma? The preloaded IOL systems available to date have sought to meet these requirements by enhancing one element, be it the injector or lens. However, this means that a trade-off has to be made, usually between the ease of use or surgical outcomes. At Rayner, we believe that the only way to create a true fully preloaded micro incision cataract surgery (MICS) injection system that works consistently without compromise is to design the system as one both lens and injector. This was the inspiration behind our new RayOne. When creating RayOne, we developed our MICS lens and unique patented Lock & Roll TM technology as part of the same design process; this combination has resulted in the smallest fully preloaded injector available (1.65 mm nozzle). Our new RayOne MICS lens is an enhanced version of the tried-and-tested C-flex and Superflex platform, combined into a single 6 mm optic design. We have retained the material and design benefits of our original lenses, without compromising on proven stability or optical performance.

RayOne easy to use injector Single handed plunger with minimal force required True 2-step system Ergonomic design for ease of handling Unique patented Lock & Roll technology for consistent delivery Sub 2.2 mm incision RayOne enhanced 6 mm optic Available as spheric or aberration-neutral aspheric optic Based on proven haptic technology for excellent stability 1,2 Amon-Apple enhanced square edge for minimal PCO 1.7% at 24 months 7 Zero glistenings Largest fully preloaded power range on the market -10.0 D to +34.0 D

RayOne with patented Lock & Roll technology for a smoother, more consistent rolling and delivery of the lens via micro incision Lock & Roll technology 1.65 mm RayOne nozzle Rolls the lens to under half its size before injection Consistent, smoother delivery Reduces insertion forces Fully enclosed cartridge with no lens handling Reduces the risk of lens damage Minimises chance of contamination Smallest fully preloaded injector nozzle Ease of insertion Compatible with MICS Parallel sided for minimal stretch Sub 2.2 mm wound-in delivery Maintains incision architecture 4.5 mm 1.65 mm 450 Consistently locked and rolled to under half its size in one simple action Easy to use, true 2-step system Simple and intuitive Minimal learning curve Minimises error Full power range, from -10.0 to +34.0 Dioptres Largest fully preloaded power range available One system for all patients Increase efficiencies Designed to enable repeatability Reduces operating time Step 1. Insert OVD into cartridge via port Step 2. Lock cartridge ready for implantation 1.65mm The smallest The smallest fully preloaded fully preloaded injector injector nozzle nozzle Enabling true micro incision

When considering an intraocular lens, what s important to you? Reliable optical outcomes and a low rate of post-operative complications Designed with Rayner s Anti-Vaulting Haptic (AVH) Technology. Our RayOne IOL provides proven rotational and centrational stability, and excellent fixation in the capsular bag 1 Superb centration - Maximum offset of only 1 mm 3 months after surgery 2 Excellent rotational and torsional stability - 3.1 mean IOL rotation 3 months after surgery 2 Aberration-neutral technology for optimal visual quality and functional visual acuity in all light conditions Designed with an aspheric anterior surface that creates no spherical aberration. Studies have demonstrated that aberration-neutral technology: Offers improved contrast sensitivity compared with spherical IOLs 3,4 Provides better low light level visual acuity than spherical IOLs 14 Can offer more depth of field than aberration-negative IOLs by retention of the patient s natural level of corneal spherical aberration 6 Are less susceptible to the effects of decentration than aberration-negative IOLs 11 Twice as many patients* preferred the aberration-neutral IOL than aberration-negative 6 Three times fewer reports of visual disturbances with the aberration-neutral IOL than aberration-negative 6 Reducing dysphotopsia by design 12 Rayner s Enhanced Square Edge Technology shows no general increase in glare from previous models without a square edge 7 The low refractive index (1.46) of Rayacryl 360 Optimised Barrier to reduce PCO Low Nd: YAG capsulotomy rates Rayner s 360 Amon-Apple Enhanced Square Edge creates an optimum barrier to reduce epithelial cell migration including at the haptic-optic junction 7,5 ND:YAG CAPSULOTOMY RATES 7 MEAN TIME TO ND:YAG CAPSULOTOMY 7 At 12 months 0.6% 9.3 ± 5.5 months (range 2.6-22.7 months) At 24 months 1.7% Follow-up period: 5.3 29 months Study of 3,461 patients receiving Rayner 570C IOLs over a 24 month period, Nd:YAG capsulotomy rates were extremely low and comparable with hydrophobic acrylic lenses with square-edge optics. 7

Vacuole free material for a glistening free IOL Single piece IOL created from Rayacryl an homogeneous material free of microvacuoles, resulting in a glistening free IOL 8 Compressible material for delivery through a micro incision Excellent handling characteristics with controlled unfolding within the capsular bag Low silicone oil adherence 9 Excellent uveal biocompatibility 13 Hydrophilic acrylic material with low inflammatory response 10 References: 1. Claoué C. Clinical and Surgical Ophthalmology 2008; 26(6): 198-200 2. Alberdi R et al. J Refract Surg. 2012; 28(10):696-700 3. Nanavaty MA et al. J Cataract Refract Surg. 2009; 35:663 671 4. Yagci R et al. Eur J Ophthalmol. 2014 Jul 24; 24(5):688-92 5. Vyas AV et al. J Cataract Refract Surg 2007; 33:81-87 6. Johansson B et al. J Cataract Refract Surg. 2007; 33:1565 1572 7. Mathew RG and Coombes AGA. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec; 41(6):651-5 8. Rayner. Data on File. White paper 9. McLoone E et al. Br J Ophthalmol. 2001; 85:543 545 10. Richter-Mueksch S et al. J Cataract Refract Surg. 2007; 33:1414 1418 11. Altmann GE et al. J Cataract Refract Surg. 2005; 31(3): 574-585 12. Cezón Prieto J and Bautista MJ. J Cataract Refract Surg. 2010; 36:1508-1516 13. Tomlins PJ et al. J Cataract Refract Surg. 2014; 40:618 625 14. Pepose JS et al. Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):965-73 *Of those who expressed a preference

For optimal visual quality and reliable outcomes choose RayOne True 2-step preloaded system Easy to use Minimises error Increases efficiency Enhanced 6.0 mm optic Minimal PCO* Proven technology for excellent stability 0 Zero glistenings One system for the entire power range -10.0 D to +34.0 D Consistent through sub 2.2 mm incisions RAYONE ASPHERIC Optic diameter Overall length Estimated A-constant Power range Injector nozzle size 6.00 mm 12.5 mm 118.6 (optical biometry) -10.0 D to +7.0 D (1.0 D increments, inc. plano) +8.0 D to +30.0 D (0.5 D increments) +31.0 D to +34.0 D (1.0 D increments) 1.65 mm Recommended for use with Ophteis FR Pro: Sodium Hyaluronate & sorbitol Ophteis FR Pro with sorbitol is a viscous cohesive designed to exceed core OVD requirements and enhance endothelial protection during surgery. In addition to a 2% NaHa concentration, FR Pro contains 4% sorbitol, a proven free radical scavenger. During a three-second phaco time study, FR Pro showed greater overall average cell protection (28.4% less cell death) compared to three market-leading OVDs*. RayOne also has been validated for use with the entire Rayner Ophteis and Methylvisc OVD ranges, as well as leading competitor OVDs. *University of Brighton, UK, in vitro phaco free radical studies, data to be published. GLOBAL HQ & UK OFFICE RAYNER INTRAOCULAR LENSES LIMITED 10 Dominion Way Worthing, West Sussex BN14 8AQ. United Kingdom Tel: +44 (0) 1903 258 900 Email: iol_enquiries@rayner.com Web: rayner.com UK CUSTOMER SERVICE Tel: +44 (0) 1903 854 560 Email: orders@rayner.com Discover why RayOne is in a class of its own visit rayner.com/rayone GERMANY CUSTOMER SERVICE Tel: +49 30 6290783-0 Email: info.de@rayner.com ITALIAN CUSTOMER SERVICE Tel: +39 02 94752926 Email: ordini@rayner.com SPANISH CUSTOMER SERVICE Email: pedidos@rayner.com Regulatory restrictions may apply in certain markets. 2016 Rayner Intraocular Lenses Limited. RayOne and Lock & Roll are registered marks of Rayner. EC 2016-51 08/16